Ken Bean, PhD
Chief Scientific Officer
FDA veteran and co-leader of the Hepatitis B cure team. A former Biogen scientist, Ken was awarded the National Medal of Technology and Innovation for his groundbreaking regulatory and scientific contributions. At xBxBIO, he leads scientific strategy, regulatory affairs, and product validation.

Shankar Iyer
Chief Executive Officer
Former Global Head of Life Sciences Digitization at Amazon Web Services. Shankar previously served as EVP at Edwards Lifesciences and has led enterprise-scale health platform deployment globally. He directs the vision and commercialization strategy for xBxBIO.

Dr. Shabbir Dharamsey
Chief Medical Officer
Practicing interventional cardiologist and academic professor. As CMO, Dr. Dharamsey ensures clinical relevance and precision in xBxBIO’s diagnostic models and patient workflows. He bridges the frontlines of medicine with algorithmic development.

Ashton Gowadia
Chairman & Co-Founder
Former VP at Lehman Brothers and founding hedge fund partner. Ashton brings global financial leadership to xBxBIO, guiding investor strategy, partnerships, and governance with a sharp focus on long-term impact.

Patrick Carew
Chief Operating Officer
Co-founder of Axonis Therapeutics (valued at $5B+), Patrick also served as Foundation President of John Muir Health and Associate Vice Chancellor of UC San Diego Health. He oversees operations, strategic partnerships, and health system integration.